These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15352041)

  • 41. Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation.
    Grabert RC; Cousens LP; Smith JA; Olson S; Gall J; Young WB; Davol PA; Lum LG
    Clin Cancer Res; 2006 Jan; 12(2):569-76. PubMed ID: 16428502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.
    Csóka M; Strauss G; Debatin KM; Moldenhauer G
    Leukemia; 1996 Nov; 10(11):1765-72. PubMed ID: 8892680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting.
    Schraa AJ; Kok RJ; Berendsen AD; Moorlag HE; Bos EJ; Meijer DK; de Leij LF; Molema G
    J Control Release; 2002 Oct; 83(2):241-51. PubMed ID: 12363450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.
    De Jong R; Brouwer M; Rebel VI; Van Seventer GA; Miedema F; Van Lier RA
    Immunology; 1990 Jul; 70(3):357-64. PubMed ID: 2143171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma.
    Demanet C; Brissinck J; De Jonge J; Thielemans K
    J Hematother; 1995 Oct; 4(5):363-8. PubMed ID: 8581370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
    Temming K; Meyer DL; Zabinski R; Dijkers EC; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(6):1385-94. PubMed ID: 17105215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bispecific single-chain diabody-mediated killing of endoglin-positive endothelial cells by cytotoxic T lymphocytes.
    Korn T; Müller R; Kontermann RE
    J Immunother; 2004; 27(2):99-106. PubMed ID: 14770081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells.
    Liu SQ; Shiba R; Kim BS; Saijo K; Ohno T
    Cancer Immunol Immunother; 1994 Nov; 39(5):279-85. PubMed ID: 7987858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Situ Self-Assembly of Bispecific Peptide for Cancer Immunotherapy.
    Wang MD; Lv GT; An HW; Zhang NY; Wang H
    Angew Chem Int Ed Engl; 2022 Mar; 61(10):e202113649. PubMed ID: 34994999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α
    Paulus J; Sewald N
    Front Chem; 2022; 10():869639. PubMed ID: 35480387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Redirecting Killer T Cells through Incorporation of Azido Sugars for Tethering Ligands.
    Wang W; Zhao Z; Zhang Z; Zhang C; Xiao S; Ye X; Zhang L; Xia Q; Zhou D
    Chembiochem; 2017 Nov; 18(21):2082-2086. PubMed ID: 28862366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.
    McNerny DQ; Kukowska-Latallo JF; Mullen DG; Wallace JM; Desai AM; Shukla R; Huang B; Banaszak Holl MM; Baker JR
    Bioconjug Chem; 2009 Oct; 20(10):1853-9. PubMed ID: 20711425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifunctional Glycoconjugates for Recruiting Natural Antibodies against Cancer Cells.
    Liet B; Laigre E; Goyard D; Todaro B; Tiertant C; Boturyn D; Berthet N; Renaudet O
    Chemistry; 2019 Dec; 25(68):15508-15515. PubMed ID: 31613028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA-Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing.
    Pan L; Cao C; Run C; Zhou L; Chou JJ
    Adv Sci (Weinh); 2020 Jan; 7(2):1900973. PubMed ID: 31993277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model for population distributions of lymphocyte-target cell conjugates.
    Garcia-Peñarrubia P; Koster FT; Bankhurst AD; Galvez J
    J Theor Biol; 1989 May; 138(1):77-92. PubMed ID: 2626065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ImmTACs: Novel bi-specific agents for targeted cancer therapy.
    Oates J; Jakobsen BK
    Oncoimmunology; 2013 Feb; 2(2):e22891. PubMed ID: 23525668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limitations in immunotherapy with CD3 antibodies: comment on the article by Drs. Chatenoud and Bach.
    Bresson D; von Herrath M
    Rev Diabet Stud; 2005; 2(4):187-9; discussion 190-1. PubMed ID: 17491693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.